크라운 바이오사이언스, 면역치료제용 인간화 표적 모델 출시

NEXT STORY
TiGenix: Publication of prospectus and response memorandum for Takeda takeover bid commencing on April 30, 2018
PREV STORY
Vical Announces News Release and Conference Call Schedule for First Quarter 2018 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Strategic partnership enables physicians to conduct clinical research and offer new clinical therapies to their patients

CHICAGO, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) has partnered with Elligo Health Research ...

author_avatar
NASDAQ Market News

ZIOPHARM Oncology to Host Second-Quarter 2017 Financial Results and Corporate Update Conference Call on July 31, 2017 at 4:30 p.m. ET

BOSTON, July 24, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Coherus Prices Public Offering of Common Stock

REDWOOD CITY, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today ...

author_avatar
NASDAQ Market News